Business Context and Reporting Period
This Form 8-K is filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) for the reporting period ending December 21, 2012. The filing discloses the entry into a Material Definitive Agreement regarding a modification to the company's existing business financing.
Key Financial Metrics and Debt
- Credit Limit: Increased to $10.0 million for advances under the Business Financing Agreement.
- Sublimit: Non-formula advances are capped at $6.0 million.
- Interest Rate: Adjusted to the prime rate plus 0.50%.
- Maturity Date: Extended to December 16, 2014.
- Liquidity and Cash Flow: The filing text does not provide specific values for revenue, profit, cash flow, or current liquidity positions.
Material Changes Versus Prior Period
On December 21, 2012, the company amended its Business Financing Agreement with Bridge Bank, National Association (originally dated December 16, 2010). Material changes include:
- Establishment of a higher credit limit.
- Authorization of eligible receivables advances and non-formula advances.
- Extension of the loan maturity date by approximately two years.
- Modification of the interest rate calculation.
- Amendments to definitions, covenants, and financial reporting obligations.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the terms of the financing agreement. The agreement remains in full force and effect except for the specific amendments noted. No unusual items or contingencies are disclosed in the text of this report.
Investor Verification Checklist
- Verify the full text of the Business Financing Modification Agreement (Exhibit 4.8B) for detailed covenants and default provisions.
- Confirm the current utilization of the $10.0 million credit facility and the $6.0 million non-formula sublimit.
- Review the company's most recent 10-K or 10-Q to assess overall liquidity and debt service capabilities relative to the new terms.
- Monitor the prime rate fluctuations to understand potential changes in interest expense.